trial · primary record
ZEN-3694
Metastatic Castration-resistant Prostate Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 50 |
| Primary completion | 2031-08-30 |
| Primary endpoint | Clinical/radiographic progression free survival (PFS) with BATZEN |
| Registry ID | NCT06922318 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:45:15.924Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06922318
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.